191
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

B-cell acute lymphoblastic leukemia after lenalidomide maintenance therapy; a deleterious adverse event that needs further investigation. Report of three cases and review of the literature

, , , , , , , , , , , , & show all
Pages 1701-1705 | Received 16 Mar 2023, Accepted 30 Jun 2023, Published online: 17 Jul 2023
 

Author contributions

Arribas I and Maluquer C contributed equally to this letter

Patient consent

Written informed consent has been obtained to publish the details from the affected individuals.

Disclosure statement

No potential conflict of interest was reported by the author(s)

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.